Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
25 hedge funds and large institutions have $83.4M invested in Enzymotec Ltd in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
39% more funds holding
Funds holding: 18 → 25 (+7)
23% more capital invested
Capital invested by funds: $67.7M → $83.4M (+$15.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
+$7.18M |
| 2 |
Goldman Sachs
New York
|
+$1.98M |
| 3 |
Renaissance Technologies
New York
|
+$567K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$397K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$153K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$398K |
| 2 |
Millennium Management
New York
|
-$379K |
| 3 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$187K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.7K |
ENZY Hedge Fund Activity: Q3 2015 in Review
25 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q3 2015, worth a combined $83.4M — up 23% from $67.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ENZY positions and 1 closed out — a net gain of 7 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Tiger Management, opening a new position worth an estimated $7.18M. The largest seller was Fidelity Investments, cutting an estimated $398K.
- 25 institutional investors held Enzymotec Ltd (ENZY) as of Q3 2015, up from 18 in Q2 2015.
- Funds reported $83.4M of Enzymotec Ltd stock for Q3 2015, up 23% quarter-over-quarter.
- 8 funds opened new Enzymotec Ltd positions in Q3 2015 and 1 closed out, a net change of +7 holders.
- The largest Enzymotec Ltd buyer in Q3 2015 was Tiger Management, an estimated $7.18M added.
- The largest Enzymotec Ltd seller in Q3 2015 was Fidelity Investments, an estimated $398K sold.
Based on aggregated 13F filings for Q3 2015.